Setting the stage Prevalence of neonatal RDS Risk factors and relationship with gestational age (review of neonatal lung development) Clinical features of disease Differential diagnoses

Treating neonatal RDS Imaging of neonatal RDS Prenatal prevention of RDS: Corticoteroids, delaying labor, referring to a specialist Pharmacotherapy: Corticosteroids, surfactant replacement therapy Review: Role of endogenous surfactant Emerging research Respiratory support: CPAP, intubation Differing schools of thought: Inhaled nitric oxide, caffeine, high-flow nasal cannula Case studies: Prevention, diagnosis, and management

By the end of the session the participant will be able to:

• Identify the pathophysiology, clinical features, and strategies for diagnosis of neonatal RDS.
• Review current and emerging options for the management of neonatal RDS.
• Develop pre- and postnatal treatment plans for the prevention and management of neonatal RDS.

ACCME Activity #201861268

ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.

As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.

Faculty Disclosures:

Jack H. Sills, MD, Clinical Professor Pediatrics, University of California, Invine, CA has no relevant conflicts of interest to disclose.

Peer reviewer disclosure:

Rangasamy Ramanathan, MD, discloses that he has received research grant support and consulting honoraria from Cheisi.

Jae Kim, MD, discloses that they have received consulting honoraria from Medela, Nutricia, and Fujifilm; and have stock ownership in Astarte Medical and Nicolette.

Disclosures of Educational Planners: Charles Turck, PharmD, BCPS, BCCCP, CEO of
ScientiaCME, has no relevant conflicts of interest to disclose.

Commercial Support Disclosure: This program is supported by an educational grant from Chiesi.

• Read the learning objectives above
• Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
• View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
• Minimum participation threshold: Take the post-test. A score of 70% or higher is required to pass and proceed to the activity evaluation.
• Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.

Cultural/Linguistic Competence & Health Disparities

*Required to view Printable PDF Version